157 related articles for article (PubMed ID: 8496916)
1. Synthesis and biological activity of spirocyclic benzopyran imidazolone potassium channel openers.
Gadwood RC; Kamdar BV; Dubray LA; Wolfe ML; Smith MP; Watt W; Mizsak SA; Groppi VE
J Med Chem; 1993 May; 36(10):1480-7. PubMed ID: 8496916
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+/-)-cromakalim.
Sebille S; Gall D; de Tullio P; Florence X; Lebrun P; Pirotte B
J Med Chem; 2006 Jul; 49(15):4690-7. PubMed ID: 16854075
[TBL] [Abstract][Full Text] [Related]
3. New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position.
Florence X; Sebille S; Tullio Pd; Lebrun P; Pirotte B
Bioorg Med Chem; 2009 Nov; 17(22):7723-31. PubMed ID: 19822435
[TBL] [Abstract][Full Text] [Related]
4. New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers.
Sebille S; de Tullio P; Florence X; Becker B; Antoine MH; Michaux C; Wouters J; Pirotte B; Lebrun P
Bioorg Med Chem; 2008 May; 16(10):5704-19. PubMed ID: 18406154
[TBL] [Abstract][Full Text] [Related]
5. Potassium channel activators based on the benzopyran substructure: synthesis and activity of the C-8 substituent.
Thompson R; Doggrell S; Hoberg JO
Bioorg Med Chem; 2003 Apr; 11(8):1663-8. PubMed ID: 12659752
[TBL] [Abstract][Full Text] [Related]
6. Relaxant activity of 4-amido-3,4-dihydro-2H-1-benzopyran-3-ols and 4-amido-2H-1-benzopyrans on guinea pig isolated trachealis.
Buckle DR; Arch JR; Fenwick AE; Houge-Frydrych CS; Pinto IL; Smith DG; Taylor SG; Tedder JM
J Med Chem; 1990 Nov; 33(11):3028-34. PubMed ID: 2231602
[TBL] [Abstract][Full Text] [Related]
7. Activation by cromakalim of pre- and post-synaptic ATP-sensitive K+ channels in substantia nigra.
Häusser MA; de Weille JR; Lazdunski M
Biochem Biophys Res Commun; 1991 Jan; 174(2):909-14. PubMed ID: 1899575
[TBL] [Abstract][Full Text] [Related]
8. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
[TBL] [Abstract][Full Text] [Related]
10. Relaxant activity of 6-cyano-2,2-dimethyl-2H-1-benzopyran-4-carboxamides and -thiocarboxamides and their analogues in guinea pig trachealis.
Arch JR; Buckle DR; Carey C; Parr-Dobrzanski H; Faller A; Foster KA; Houge-Frydrych CS; Pinto IL; Smith DG; Taylor SG
J Med Chem; 1991 Aug; 34(8):2588-94. PubMed ID: 1875351
[TBL] [Abstract][Full Text] [Related]
11. The individual enantiomers of cis-cromakalim possess K+ channel opening activity.
Quast U; Villhauer EB
Eur J Pharmacol; 1993 Apr; 245(2):165-71. PubMed ID: 8491256
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and aldose reductase inhibitory activity of 2-substituted 6-fluoro-2,3-dihydrospiro[4H-1-benzopyran-4,4'-imidazolidine]-2',5'-dio nes.
Unno R; Yamaguchi T; Usui T; Kakigami T; Fukushima M; Mizuno K; Baba Y; Kurono M
Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1474-8. PubMed ID: 7923471
[TBL] [Abstract][Full Text] [Related]
13. Spirocyclic benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel.
Breschi MC; Calderone V; Digiacomo M; Manganaro M; Martelli A; Minutolo F; Rapposelli S; Testai L; Tonelli F; Balsamo A
J Med Chem; 2008 Nov; 51(21):6945-54. PubMed ID: 18925735
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]-heptenyloxy)benzopyran derivatives and their analogues.
Horino H; Mimura T; Kagechika K; Ohta M; Kubo H; Kitagawa M
Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):602-9. PubMed ID: 9579035
[TBL] [Abstract][Full Text] [Related]
15. Evidence that acetylcholine-mediated hyperpolarization of the rat small mesenteric artery does not involve the K+ channel opened by cromakalim.
McPherson GA; Angus JA
Br J Pharmacol; 1991 May; 103(1):1184-90. PubMed ID: 1908733
[TBL] [Abstract][Full Text] [Related]
16. Cardioselective antiischemic ATP-sensitive potassium channel openers. 2. Structure-activity studies on benzopyranylcyanoguanidines: modification of the benzopyran ring.
Atwal KS; Grover GJ; Ferrara FN; Ahmed SZ; Sleph PG; Dzwonczyk S; Normandin DE
J Med Chem; 1995 May; 38(11):1966-73. PubMed ID: 7783128
[TBL] [Abstract][Full Text] [Related]
17. Effects of K+ channel agonists cromakalim and pinacidil on rat basilar artery smooth muscle cells are mediated by Ca(++)-activated K+ channels.
Stockbridge N; Zhang H; Weir B
Biochem Biophys Res Commun; 1991 Nov; 181(1):172-8. PubMed ID: 1958186
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue.
Norman NR; Toombs CF; Khan SA; Buchanan LV; Cimini MG; Gibson JK; Meisheri KD; Shebuski RJ
Pharmacology; 1994 Aug; 49(2):86-95. PubMed ID: 7972325
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
Quast U; Cook NS
J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
Atwal KS
J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
